Services

Listings
  • CAR-T Construction Service

    CAR-T Construction Service

    Drug Development Shirley (New York) April 28, 2018 Check with publisher

    As a CAR technology leader, Creative Biolabs has established an unparalleled platform for Chimeric Antigen Receptor (CAR) modified T cell construction, which can satisfy various needs for developing treatments of multiply cancers in preclinical studi...

  • De Novo TCR (T-cell Receptor) Sequencing Service

    De Novo TCR (T-cell Receptor) Sequencing Service

    Immunology (United States ) April 20, 2017 Check with publisher

    Creative Biolabs is pleased to introduce an unparalleled De Novo TCR (T-cell Receptor) Sequencing service, which has been developed based on our world-leading platform of de novo antibody sequencing using our proprietary “Database Assisted Shotgun Se...

  • Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC

    Anti-CD33 (clone HuM195)-AcBut-Calicheamicin ADC

    Drug Development Shirley (New York) November 15, 2017 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody (clone HuM195) conjugated via a AcBut linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor medi...

  • 6th Annual Cell Culture & Bioprocessing Congress 2017

    6th Annual Cell Culture & Bioprocessing Congress 2017

    Cell Biology & Microbiology (United Kingdom) March 31, 2017 Check with publisher

    Oxford Global Conferences presents its 6th Annual Cell Culture & Bioprocessing Congress, with our co-located 4th Annual Stem Cell Congress and 3rd Annual Cell & Gene Therapy Congress, 6 - 7 of November 2017, London, UK. View Agenda: bit.ly/16...

  • De Novo Biosimilar monoclonal antibodies Sequencing Service

    De Novo Biosimilar monoclonal antibodies Sequencing Service

    Immunology (United States ) April 20, 2017 Check with publisher

    Creative Biolabs provides monoclonal antibodies sequencing service for biosimilar development, which provides full sequence coverage of the antibodies with 100% accuracy. Functional Biosimilar monoclonal antibodies can be sequenced by subunit with 10...

  • Anti-CD33mAb-DOTA-G3FC ADC

    Anti-CD33mAb-DOTA-G3FC ADC

    Drug Development Shirley (New York) November 15, 2017 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-G3FC linker to a drug.

  • De Novo Rodent Antibody Sequencing Service

    De Novo Rodent Antibody Sequencing Service

    Immunology (United States ) April 20, 2017 Check with publisher

    Scientists from Creative Biolabs have developed “Database Assisted Shotgun Sequencing" (DASS) technology, which provides rodent antibody sequencing service. Our De Novo rodent antibody sequencing utilizes computational approaches to deduce the sequen...

  • Anti-CD33mAb-DOTA-NCS ADC

    Anti-CD33mAb-DOTA-NCS ADC

    Drug Development Shirley (New York) November 15, 2017 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-NCS linker to a drug.

  • De Novo Human/Humanized Antibody Sequencing Service

    De Novo Human/Humanized Antibody Sequencing Service

    Immunology (United States ) April 20, 2017 Check with publisher

    The generation of human or humanized antibodies to human antigens is of particular interest for the treatment of a variety of diseases. Creative Biolabs is pleased to present world-leading De Novo Human/Humanized Antibody Sequencing service. Scientis...

  • Anti-CD33mAb-DOTA-SH ADC

    Anti-CD33mAb-DOTA-SH ADC

    Drug Development Shirley (New York) November 15, 2017 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-SH linker to a drug.

  • De Novo Chicken IgYs Sequencing Service

    De Novo Chicken IgYs Sequencing Service

    Immunology (United States ) April 20, 2017 Check with publisher

    Creative Biolabs provides peerless De Novo Chicken IgYs Sequencing Service, which has been developed based on our unique platform of De Novo Antibody Sequencing using our specific and world-leading “Database Assisted Shotgun Sequencing" (DASS) techno...

  • Anti-CD33mAb-DOTA-SH ADC

    Anti-CD33mAb-DOTA-SH ADC

    Drug Development Shirley (New York) November 15, 2017 Check with publisher

    This ADC product is comprised of an anti-CD33 monoclonal antibody conjugated via a DOTA-SH linker to a drug.